Abstract
Introduction: In recent years, resting-state functional magnetic resonance imaging (rsfMRI) has been increasingly used as a noninvasive and practical method in different areas of neuroscience and psychology for recognizing brain’s mechanism as well as diagnosing neurological diseases. In this work, we use rs-fMRI data for diagnosing Alzheimer's disease.
Materials and Methods: To do that, by using the rs-fMRI of a patient, we computed the time series of some anatomical regions and then applied the Latent Low Rank Representation method to extract suitable features. Next, based on the extracted features, we apply a Support Vector Machine (SVM) classifier to determine whether the patient belongs to a healthy category, mild stage of the disease or Alzheimer's stage.
Results: The obtained classification accuracy for the proposed method is more than 97.5%.
Conclusion: We performed different experiments on a database of rs-fMRI data containing the images of 43 healthy subjects, 36 mild cognitive impairment patients and 32 Alzheimer’s patients and the obtained results demonstrated that the best performance is achieved when the SVM with Gaussian kernel and the features of only 7 regions were used.
Keywords: Functional magnetic resonance imaging (fMRI), alzheimer disease, resting-state network, latent low rank representation, SVM.
Current Signal Transduction Therapy
Title:Alzheimer Disease Diagnosis from fMRI Images Based on Latent Low Rank Features and Support Vector Machine (SVM)
Volume: 16 Issue: 2
Author(s): Nastaran Shahparian, Mehran Yazdi*Mohammad Reza Khosravi
Affiliation:
- School of Electrical and Computer Engineering, Shiraz University,Iran
Keywords: Functional magnetic resonance imaging (fMRI), alzheimer disease, resting-state network, latent low rank representation, SVM.
Abstract:
Introduction: In recent years, resting-state functional magnetic resonance imaging (rsfMRI) has been increasingly used as a noninvasive and practical method in different areas of neuroscience and psychology for recognizing brain’s mechanism as well as diagnosing neurological diseases. In this work, we use rs-fMRI data for diagnosing Alzheimer's disease.
Materials and Methods: To do that, by using the rs-fMRI of a patient, we computed the time series of some anatomical regions and then applied the Latent Low Rank Representation method to extract suitable features. Next, based on the extracted features, we apply a Support Vector Machine (SVM) classifier to determine whether the patient belongs to a healthy category, mild stage of the disease or Alzheimer's stage.
Results: The obtained classification accuracy for the proposed method is more than 97.5%.
Conclusion: We performed different experiments on a database of rs-fMRI data containing the images of 43 healthy subjects, 36 mild cognitive impairment patients and 32 Alzheimer’s patients and the obtained results demonstrated that the best performance is achieved when the SVM with Gaussian kernel and the features of only 7 regions were used.
Export Options
About this article
Cite this article as:
Shahparian Nastaran, Yazdi Mehran *, Khosravi Reza Mohammad , Alzheimer Disease Diagnosis from fMRI Images Based on Latent Low Rank Features and Support Vector Machine (SVM), Current Signal Transduction Therapy 2021; 16 (2) . https://dx.doi.org/10.2174/1574362414666191202144116
DOI https://dx.doi.org/10.2174/1574362414666191202144116 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Editorial (Thematic Issue: Molecular Targeting for Development of Novel Therapeutic Strategies in Brain Diseases: Myth or Reality?)
CNS & Neurological Disorders - Drug Targets Ziconotide: Neuronal Calcium Channel Blocker for Treating Severe Chronic Pain
Current Medicinal Chemistry Radionuclide Imaging in Drug Development
Current Pharmaceutical Design A Mesenchymal Stem Cell Line Transplantation Improves Neurological Function and Angiogenesis in Intraventricular Amyloid β-Infused Rats
Current Alzheimer Research Low Plasma Leptin in Cognitively Impaired ADNI Subjects: Gender Differences and Diagnostic and Therapeutic Potential
Current Alzheimer Research Design, Synthesis and Acetylcholinesterase and Butylcholinesterase Inhibition Activity of Novel 1-(Alkyl)-3-(2-oxo-2H-chromenyloxy Acetamido) methylpyridinium Salts
Letters in Organic Chemistry Th17 Cells: The Role in Immunity
Current Immunology Reviews (Discontinued) Current Therapy of Drugs in Amyotrophic Lateral Sclerosis
Current Neuropharmacology Mitochondrial Dysfunction in Depression
Current Neuropharmacology Microwave Induced One Pot Ugi Multicomponent Reaction of Fluoroquino Lone Scaffolds: Their Biological Evaluation
Current Green Chemistry Citicoline and Retinal Ganglion Cells: Effects on Morphology and Function
Current Neuropharmacology Aberrant Expression of MicroRNAs in B-cell Lymphomas
MicroRNA Gender Differences in P-Glycoprotein Expression and Function: Effects on Drug Disposition and Outcome
Current Drug Metabolism Elevated Inflammatory Parameter Levels Negatively Impact Populations of Circulating Stem Cells (CD133+), Early Endothelial Progenitor Cells (CD133+/VEGFR2+), and Fibroblast Growth Factor in Stroke Patients
Current Neurovascular Research Neuropsychological Effects of Mercury Exposure Among Dentists in Monastir City
Recent Patents on Inflammation & Allergy Drug Discovery Regulation of Blood Flow by Prostaglandins
Current Vascular Pharmacology β -Amyloid: A Disease Target or a Synaptic Regulator Affecting Age-Related Neurotransmitter Changes?
Current Pharmaceutical Design Microparticles in Health and Disease: Small Mediators, Large Role?
Current Vascular Pharmacology The Function of Tyrosine Hydroxylase in the Normal and Parkinsonian Brain
CNS & Neurological Disorders - Drug Targets Enhanced Selectivity Screening of GPCR Ligands Using a Label-Free Cell Based Assay Technology
Combinatorial Chemistry & High Throughput Screening